| Health / Medical Topics |
Indium In 111-CMD-193
A radiolabeled antibody-targeted antineoplastic antibiotic consisting of the enediyne antibiotic calicheamicin conjugated with anti-Lewis Y antibody and labeled with indium In 111. In 111 CMD-193 binds to Lewis Y antigen-expressing tumor cells via its antibody moiety and is internalized; subsequently, the calicheamicin moiety binds to the minor groove of tumor cell DNA, causing double-strand DNA breaks, the inhibition of DNA synthesis, and apoptosis. The indium In 111 radiolabel allows the detection of CMD-193 distribution and tumor localization using gamma scintigraphy. (NCI Thesaurus)
YOU MAY ALSO LIKE
A substance being studied in the imaging of breast cancer and some other types of cancer. It is made by attaching a…
A substance being studied in the imaging of some types of cancer. M5A is a monoclonal antibody that binds to a protein…
A radioimmunoconjugate composed of a humanized recombinant monoclonal antibody directed against the extracellular dimerization domain of the tyrosine kinase receptor human epidermal…
An anticancer drug belonging to a family of drugs called radiopharmaceuticals.
A sterile, non-pyrogenic, isotonic solution of radioactive indium In 111 diethylenetriamine pentaacetate (DTPA). When administered intrathecally, indium In 111 pentetate percolates up…
The humanized monoclonal antibody huPAM4, directed against the pancreatic cancer antigen MUC-1 and labeled with the gamma-emitting radioisotope indium In 111, with…
